AQR Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Buy |
432,403
+122,131
| +39% | +$1.42M | ﹤0.01% | 1286 |
|
|
2025
Q1 | $2.26M | Buy |
310,272
+97,444
| +46% | +$711K | ﹤0.01% | 1537 |
|
|
2024
Q4 | $1.28M | Sell |
212,828
-49,136
| -19% | -$295K | ﹤0.01% | 1759 |
|
|
2024
Q3 | $1.34M | Buy |
261,964
+79,888
| +44% | +$409K | ﹤0.01% | 1705 |
|
|
2024
Q2 | $635K | Buy |
182,076
+129,201
| +244% | +$451K | ﹤0.01% | 1940 |
|
|
2024
Q1 | $168K | Buy |
52,875
+13,350
| +34% | +$42.5K | ﹤0.01% | 2282 |
|
|
2023
Q4 | $194K | Buy |
39,525
+26,313
| +199% | +$129K | ﹤0.01% | 2222 |
|
|
2023
Q3 | $72K | Sell |
13,212
-12,449
| -49% | -$67.8K | ﹤0.01% | 2262 |
|
|
2023
Q2 | $172K | Sell |
25,661
-15,962
| -38% | -$107K | ﹤0.01% | 2098 |
|
|
2023
Q1 | $360K | Sell |
41,623
-28,794
| -41% | -$249K | ﹤0.01% | 1883 |
|
|
2022
Q4 | $525K | Buy |
70,417
+30,856
| +78% | +$230K | ﹤0.01% | 1797 |
|
|
2022
Q3 | $282K | Sell |
39,561
-48,309
| -55% | -$344K | ﹤0.01% | 1962 |
|
|
2022
Q2 | $688K | Sell |
87,870
-75,420
| -46% | -$591K | ﹤0.01% | 1563 |
|
|
2022
Q1 | $2.27M | Buy |
+163,290
| New | +$2.27M | ﹤0.01% | 1112 |
|
|
2021
Q2 | – | Sell |
-18,721
| Closed | -$734K | – | 2215 |
|
|
2021
Q1 | $734K | Buy |
+18,721
| New | +$734K | ﹤0.01% | 1684 |
|